Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: TOVX )

1.260 -0.020 (-1.56%)
Streaming Delayed Price Updated: 9:47 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TOVX

< Previous 1 2 3 Next >
What's Going On With Theriva Biologics (TOVX) Stock?
Theriva Biologics shares are trading lower by 8.4% Monday morning. The company announced a 1-for-25 reverse stock split. 
Via Benzinga
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q2 2024
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers
Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers 
Via News Direct
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Preview: Theriva Biologics's Earnings
Via Benzinga
Earnings Outlook For Theriva Biologics
Via Benzinga
Why Theriva Biologics Shares Are Booming Today
Theriva Biologics Inc (AMEX:TOVX) shares are trading higher Wednesday after the FDA granted orphan drug designation to VCN-01. 
Via Benzinga
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
--News Direct-- 
Via News Direct
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q1 2024
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers
Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers 
Via News Direct
Earnings Scheduled For March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million. 
Via Benzinga
How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology
--News Direct-- 
Via News Direct
For The First Time The US Is Set To Hit 2 Million New Cancer Cases: Theriva Biologics Presents Novel Solutions To The Deadliest Cancers
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
Nasdaq Moves Higher; US Crude Stocks Drop More than Projected
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is FLJ Group (FLJ) Stock Moving Today?
FLJ Group (FLJ) stock is on the move Wednesday after the apartment rental company received a delisting notice from the Nasdaq Exchange. 
Via InvestorPlace
Why Is AST SpaceMobile (ASTS) Stock Down 28% Today?
AST SpaceMobile (ASTS) stock is taking a beating on Wednesday after the satellite company priced an upsized share offering. 
Via InvestorPlace
Why Is iMedia Brands (IMBI) Stock Up 28% Today?
IMedia Brands (IMBI) stock is on the rise Wednesday despite no news from the consumer brands, entertainment, and media commerce company. 
Via InvestorPlace
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
Gainers Theriva Biologics, Inc. (NYSE: TOVX) shares surged 76.4% to $1.46 in pre-market trading after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for... 
Via Benzinga
Why Is Theriva Biologics (TOVX) Stock Up 60% Today?
Theriva Biologics (TOVX) stock is rocketing Wednesday after getting orphan drug designation from the FDA for its pancreatic cancer treatment. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on! 
Via InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.